<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26167194</article-id><article-id pub-id-type="pmc">4488551</article-id><article-id pub-id-type="doi">10.1155/2015/783761</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effect of Astaxanthin Supplementation on Salivary IgA, Oxidative
Stress, and Inflammation in Young Soccer Players</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0373-167X</contrib-id><name><surname>Baralic</surname><given-names>Ivana</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0665-9127</contrib-id><name><surname>Andjelkovic</surname><given-names>Marija</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0665-9127</contrib-id><name><surname>Djordjevic</surname><given-names>Brizita</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5245-2891</contrib-id><name><surname>Dikic</surname><given-names>Nenad</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6139-2325</contrib-id><name><surname>Radivojevic</surname><given-names>Nenad</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7227-4436</contrib-id><name><surname>Suzin-Zivkovic</surname><given-names>Violeta</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7227-4436</contrib-id><name><surname>Radojevic-Skodric</surname><given-names>Sanja</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4573-2371</contrib-id><name><surname>Pejic</surname><given-names>Snezana</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Sports Medicine Association of Serbia, Lazarevacki Drum 14, 11000 Belgrade, Serbia</aff><aff id="I2"><sup>2</sup>Institute for Bromatology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia</aff><aff id="I3"><sup>3</sup>Institute of Histology and Embryology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia</aff><aff id="I4"><sup>4</sup>Institute of Pathology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia</aff><aff id="I5"><sup>5</sup>Snezana Pejic, Department of Molecular Biology and Endocrinology, “Vinca” Institute of Nuclear Sciences, University of Belgrade, P.O. Box 522, 11000 Belgrade, Serbia</aff><author-notes><corresp id="cor1">*Snezana Pejic: <email>snezana@vinca.rs</email></corresp><fn fn-type="other"><p>Academic Editor: Francesca Mancianti</p></fn></author-notes><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>18</day><month>6</month><year>2015</year></pub-date><volume>2015</volume><elocation-id>783761</elocation-id><history><date date-type="received"><day>31</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>8</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>Copyright © 2015 Ivana Baralic et al.</copyright-statement><copyright-year>2015</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><offsets xml_i="5205" xml_f="6620" txt_i="11" txt_f="1426">The physiologic stress induced by physical activity is reflected in immune system perturbations, oxidative stress, muscle injury, and inflammation. We investigated the effect of astaxanthin (Asx) supplementation on salivary IgA (sIgA) and oxidative stress status in plasma, along with changes in biochemical parameters and total/differential white cell counts. Forty trained male soccer players were randomly assigned to Asx and placebo groups. Asx group was supplemented with 4 mg of Asx. Saliva and blood samples were collected at the baseline and after 90 days of supplementation in preexercise conditions. We observed a rise of sIgA levels at rest after 90 days of Asx supplementation, which was accompanied with a decrease in prooxidant-antioxidant balance. The plasma muscle enzymes levels were reduced significantly by Asx supplementation and by regular training. The increase in neutrophil count and hs-CRP level was found only in placebo group, indicating a significant blunting of the systemic inflammatory response in the subjects taking Asx. This study indicates that Asx supplementation improves sIgA response and attenuates muscle damage, thus preventing inflammation induced by rigorous physical training. Our findings also point that Asx could show significant physiologic modulation in individuals with mucosal immunity impairment or under conditions of increased oxidative stress and inflammation.</offsets></p></abstract></article-meta></front><body><sec id="sec1"><title><offsets xml_i="6686" xml_f="6701" txt_i="1434" txt_f="1449">1. Introduction</offsets></title><p><offsets xml_i="6712" xml_f="7024" txt_i="1450" txt_f="1762">Astaxanthin (Asx) is a red-orange carotenoid mainly produced by micro- and macroalgal species and accumulated in many marine organisms, such as shrimps, crabs, trout, and salmon. The polyene system gives astaxanthin its distinctive molecular structure, chemical properties, and light-absorption characteristics [</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="7055" xml_f="7056" txt_i="1762" txt_f="1763">1</offsets></xref><offsets xml_i="7063" xml_f="7286" txt_i="1763" txt_f="1986">]. The presence of the hydroxyl and keto moieties on each ionone ring explains some of its unique features such as higher antioxidant (AO) activity, a more polar nature than other carotenoids, and ability to be esterified [</offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="7317" xml_f="7318" txt_i="1986" txt_f="1987">2</offsets></xref><offsets xml_i="7325" xml_f="7590" txt_i="1987" txt_f="2252">]. Its both high AO potency and polar properties, make Asx an attractive nutraceutical for promising applications in human health and nutrition. Asx has also been attributed with extraordinary potential for protecting the organism against a wide range of diseases [</offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="7621" xml_f="7622" txt_i="2252" txt_f="2253">3</offsets></xref><offsets xml_i="7629" xml_f="7631" txt_i="2253" txt_f="2255">].</offsets></p><p><offsets xml_i="7638" xml_f="7801" txt_i="2256" txt_f="2419">The mucosal immune system functions as the first line of defense against pathogen invasion by preventing the attachments of infectious agents to mucosal surfaces [</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="7832" xml_f="7833" txt_i="2419" txt_f="2420">4</offsets></xref><offsets xml_i="7840" xml_f="8052" txt_i="2420" txt_f="2632">]. An important activity of the epithelia lining in gastrointestinal, respiratory, and genitourinary tract is the production of secretory IgA (sIgA), the antibody that largely dominates mucosal humoral immunity [</offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="8083" xml_f="8084" txt_i="2632" txt_f="2633">5</offsets></xref><offsets xml_i="8091" xml_f="8308" txt_i="2633" txt_f="2850">]. sIgA protects mucosal surfaces by directly cross-linking environmental microorganisms or macromolecules, thus preventing their contact with the surface of epithelial cells and hence facilitating their elimination [</offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="8339" xml_f="8340" txt_i="2850" txt_f="2851">6</offsets></xref><offsets xml_i="8347" xml_f="8437" txt_i="2851" txt_f="2941">]. Numerous studies of saliva composition have found a decreased sIgA secretion with age [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="8468" xml_f="8469" txt_i="2941" txt_f="2942">7</offsets></xref><offsets xml_i="8476" xml_f="8521" txt_i="2942" txt_f="2987">], psychological, and occupational stresses [</offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="8552" xml_f="8553" txt_i="2987" txt_f="2988">8</offsets></xref><offsets xml_i="8560" xml_f="8600" txt_i="2988" txt_f="3028">] and also in nutritional deficiencies [</offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="8631" xml_f="8632" txt_i="3028" txt_f="3029">9</offsets></xref><offsets xml_i="8639" xml_f="8793" txt_i="3029" txt_f="3183">]. In addition, mounting evidence indicates that prolonged and intensive physical exertion can cause a decrease in sIgA concentration and secretion rate [</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="8825" xml_f="8827" txt_i="3183" txt_f="3185">10</offsets></xref><offsets xml_i="8834" xml_f="9019" txt_i="3185" txt_f="3370">]. Lowered concentrations of sIgA are associated with an increased frequency of upper respiratory tract infection (URTI) episodes or with reduced protection against certain infections [</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="9051" xml_f="9053" txt_i="3370" txt_f="3372">11</offsets></xref><offsets xml_i="9060" xml_f="9062" txt_i="3372" txt_f="3374">].</offsets></p><p><offsets xml_i="9069" xml_f="9393" txt_i="3375" txt_f="3699">Intensive and sustained physical activity elevates the generation of free radicals and reactive oxygen species (ROS), thus creating an imbalance between ROS and antioxidants and leading to oxidative stress that not only causes lipid peroxidation and protein oxidation but also may have a negative impact on immune function [</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="9425" xml_f="9427" txt_i="3699" txt_f="3701">12</offsets></xref><offsets xml_i="9434" xml_f="9615" txt_i="3701" txt_f="3882">]. Asx possesses antioxidant, free radical scavenging, and anti-inflammatory properties that may affect human immune system and resistance to pathogens, although most data come from</offsets><italic><offsets xml_i="9623" xml_f="9632" txt_i="3882" txt_f="3891"> in vitro</offsets></italic><offsets xml_i="9641" xml_f="9662" txt_i="3891" txt_f="3912"> and animal studies [</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="9694" xml_f="9696" txt_i="3912" txt_f="3914">13</offsets></xref><offsets xml_i="9703" xml_f="9912" txt_i="3914" txt_f="4123">]. These studies showed that Asx stimulated a delayed-type hypersensitivity (DTH) response, the natural killer (NK) cells cytotoxic activity, and increased concentrations of IgG and IgM and B cell population [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="9944" xml_f="9946" txt_i="4123" txt_f="4125">14</offsets></xref><offsets xml_i="9953" xml_f="9954" txt_i="4125" txt_f="4126">–</offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="9986" xml_f="9988" txt_i="4126" txt_f="4128">17</offsets></xref><offsets xml_i="9995" xml_f="9997" txt_i="4128" txt_f="4130">].</offsets></p><p><offsets xml_i="10004" xml_f="10263" txt_i="4131" txt_f="4390">No published human studies exist regarding the influence of Asx ingestion on exercise-induced mucosal immunity dysfunction. One human study showed that Asx could enhance immune response and decrease a DNA oxidative damage and inflammation in healthy females [</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="10295" xml_f="10297" txt_i="4390" txt_f="4392">18</offsets></xref><offsets xml_i="10304" xml_f="10944" txt_i="4392" txt_f="5032">]. Therefore, the purpose of the present investigation was to test the hypothesis that Asx supplementation is effective in enhancing sIgA secretion in young soccer players. Compared with previous research in this field, particular strength of this study is the fact it was conducted during a regular competitive season, reflecting habitual conditions of nutrition and training program. In addition, we determined oxidative status parameters, along with biochemical and hematological profile, in order to examine possible connections among mucosal immunity, oxidative stress, inflammation, and Asx supplementation in young, healthy athletes.</offsets></p></sec><sec id="sec2"><title><offsets xml_i="10976" xml_f="10999" txt_i="5034" txt_f="5057">2. Material and Methods</offsets></title><sec id="sec2.1"><title><offsets xml_i="11031" xml_f="11044" txt_i="5058" txt_f="5071">2.1. Subjects</offsets></title><p><offsets xml_i="11055" xml_f="12119" txt_i="5072" txt_f="6136">Forty trained male soccer players, among young selection of soccer club “Partizan,” Belgrade, were recruited as experimental subjects. The participants met the following exclusion criteria: smokers, subjects with recurrent respiratory infections, subjects taking antibiotics, subjects taking immunosuppressive drugs, and alcohol abuse. Athletes as well as their parents gave the written consent after having been explained the purpose, demands, and possible risks associated with the study. The study was conducted according to the guidelines laid down in Declaration of Helsinki. Experimental procedures were approved by the Ethical Committee of Sports Medicine Association of Serbia. They were involved in a controlled training program during a 90-day period over competitive season, in which they had 5 to 7 training sessions per week with an average weekly training of 10 to 15 hours and took participation in national championship. They also had different aspects of trainings, including strength, resistance, cardio, flexibility, and proprioceptive training.</offsets></p></sec><sec id="sec2.2"><title><offsets xml_i="12153" xml_f="12193" txt_i="6138" txt_f="6178">2.2. Research Design and Supplementation</offsets></title><p><offsets xml_i="12204" xml_f="12250" txt_i="6179" txt_f="6225">Soccer players were randomly assigned to Asx (</offsets><italic><offsets xml_i="12258" xml_f="12259" txt_i="6225" txt_f="6226">N</offsets></italic><offsets xml_i="12268" xml_f="12290" txt_i="6226" txt_f="6248"> = 21) or placebo (P, </offsets><italic><offsets xml_i="12298" xml_f="12299" txt_i="6248" txt_f="6249">N</offsets></italic><offsets xml_i="12308" xml_f="12525" txt_i="6249" txt_f="6466"> = 19) groups. Under double-blind procedures, subjects received Asx (4 mg per day) or placebo supplements for 90 days. The Asx used in this study was a homogenized and spray dried biomass of the green unicellular alga</offsets><italic><offsets xml_i="12533" xml_f="12557" txt_i="6466" txt_f="6490"> Haematococcus pluvialis</offsets></italic><offsets xml_i="12566" xml_f="12779" txt_i="6490" txt_f="6703">. Both Asx and placebo capsules were manufactured by Bioreal (Sweden) and generously donated by Oriflame, Serbia. The dietary supplementation comprised of one capsule daily taken orally in conjunction with a meal.</offsets></p><p><offsets xml_i="12786" xml_f="13320" txt_i="6704" txt_f="7238">Two weeks before the first test session, subjects reported to the laboratory for orientation, measurement of body composition, and cardiorespiratory fitness. Body weight and total body fat were measured using the BC-418, 8-contact electrode device (Tanita, Tokyo, Japan), which uses bioelectrical impedance analysis for body composition analysis. Height was measured to the nearest 0.1 cm with a portable stadiometer. Body mass index (BMI) was calculated by dividing the weight in kilograms by the square of the height in meters (kg/m</offsets><sup><offsets xml_i="13325" xml_f="13326" txt_i="7238" txt_f="7239">2</offsets></sup><offsets xml_i="13332" xml_f="13337" txt_i="7239" txt_f="7244">). VO</offsets><sub><offsets xml_i="13342" xml_f="13346" txt_i="7244" txt_f="7248">2max</offsets></sub><offsets xml_i="13352" xml_f="14105" txt_i="7248" txt_f="8001"> was measured on a motor driven treadmill (Run race, Techno gym, Italy), using an indirect calorimetry system (Quark b2, Cosmed, Italy) during an incremental exercise test to volitional fatigue. Basic demographic and training data were obtained through a questionnaire. Subjects were instructed to restrain themselves from making any drastic changes in the diet. They agreed to avoid the use of vitamin/mineral supplements, antioxidant supplements, nutritional supplements, ergogenic aids, herbs, and medications known for their effect on immune function, 1 month before and during the study. Subjects recorded food intake in a 4-day food record before the first exercise test session. The food records were analyzed using CRON-O-Meter v0.9.6. software.</offsets></p><p><offsets xml_i="14112" xml_f="14652" txt_i="8002" txt_f="8542">Saliva and blood samples were collected at the onset of the study and after 90 days of supplementation, between 9:00 and 10:00 a.m., after overnight fast, before training session. For all collection points, players were restrained from water consumption 10 min before sampling. The training sessions were carried out under the same conditions, in the same place and at the same time of the day to avoid circadian variations. Each subject served as self-control to eliminate any biological variability in the response to Asx supplementation.</offsets></p></sec><sec id="sec2.3"><title><offsets xml_i="14686" xml_f="14716" txt_i="8544" txt_f="8574">2.3. Salivary Flow Measurement</offsets></title><p><offsets xml_i="14727" xml_f="15473" txt_i="8575" txt_f="9321">Whole unstimulated saliva was collected using salivettes (Sersted, Vumbrecht, Germany), by placing the cotton swab under the tongue. All saliva collections (2 min, electronically timed) were made after players had been sitting quietly for a few minutes, leaning forward, with their heads tilted. Immediately after collection, the obtained saliva samples were separated from the cotton by centrifuging at 1500 ×g for 15 minutes. The supernatant fluid was frozen at −80°C for later analysis of sIgA. Before and after saliva collection, salivettes were weighted on an analytical balance. The amount of saliva in grams was converted to milliliters assuming that the specific gravity of saliva is 1 and divided by 2 to express salivary flow in mL/min.</offsets></p></sec><sec id="sec2.4"><title><offsets xml_i="15507" xml_f="15564" txt_i="9323" txt_f="9380">2.4. Measurement of sIgA Concentration and Secretion Rate</offsets></title><p><offsets xml_i="15575" xml_f="16809" txt_i="9381" txt_f="10615">The sIgA concentration was measured by enzyme-linked immunosorbent assay (ELISA). Briefly, the test was performed on 96-well microtiter plates, which were coated with goat anti-human IgA (1 : 100 dilution, AbD Serotec, Oxford, UK) in coating buffer (0.1 M carbonate-bicarbonate, pH 9.5) and kept overnight at 4°C. On the day of analysis, plates were incubated for 60 min at room temperature before being washed with TTBS buffer (Tween 20 Tris Buffered saline, pH 7.5) and then blocked with 3% gelatin in TTBS for 2 h at room temperature. Samples were thawed and then diluted (1 : 200) with a sample diluent (1% gelatin in TTBS). Known concentrations of human secretory IgA (AbD Serotec, Oxford, UK) and controls were used to construct a standard curve. The plate was then washed before standards and samples were added to wells (in duplicate) and incubated for 1 h at room temperature. The plate was washed again before addition of diluted goat anti-human horseradish peroxidase conjugates (AbD Serotec, Oxford, UK). After incubation, the plate was washed again before addition of substrate tetramethylbenzidine (AbD Serotec, Oxford, UK) and incubated for 30 min in the dark. The colorimetric reaction was stopped via addition of 100 </offsets><italic><offsets xml_i="16817" xml_f="16818" txt_i="10615" txt_f="10616">μ</offsets></italic><offsets xml_i="16827" xml_f="17238" txt_i="10616" txt_f="11027">L of sulfuric acid, and the absorbance of solution in each well was determined at 450 nm by using ELx800 Absorbance Microplate Reader (Biotek, Winooski, USA). Regression analysis using the relation of standard sIgA concentrations and amount of absorbance (nm) was used to interpolate the concentration of sIgA in the samples. sIgA is expressed as absolute concentration and secretion rate. sIgA secretion rate (</offsets><italic><offsets xml_i="17246" xml_f="17247" txt_i="11027" txt_f="11028">μ</offsets></italic><offsets xml_i="17256" xml_f="17326" txt_i="11028" txt_f="11098">g/min) was determined by multiplying the absolute sIgA concentration (</offsets><italic><offsets xml_i="17334" xml_f="17335" txt_i="11098" txt_f="11099">μ</offsets></italic><offsets xml_i="17344" xml_f="17381" txt_i="11099" txt_f="11136">g/mL) with saliva flow rate (mL/min).</offsets></p></sec><sec id="sec2.5"><title><offsets xml_i="17415" xml_f="17443" txt_i="11138" txt_f="11166">2.5. Oxidative Stress Status</offsets></title><p><offsets xml_i="17454" xml_f="17725" txt_i="11167" txt_f="11438">For determination of oxidative status parameters, the venous blood was collected into heparin evacuated tube (Greiner Bio-one, Kremsmünster, Austria). The blood samples were centrifuged at 1500 g for 10 min, and aliquots of plasma were stored at −80°C for later analysis.</offsets></p><p><offsets xml_i="17732" xml_f="17823" txt_i="11439" txt_f="11530">Total antioxidant status (TAS) was determined using an automated method developed by Erel [</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="17855" xml_f="17857" txt_i="11530" txt_f="11532">19</offsets></xref><offsets xml_i="17864" xml_f="17896" txt_i="11532" txt_f="11564">]. A standardized solution of Fe</offsets><sup><offsets xml_i="17901" xml_f="17903" txt_i="11564" txt_f="11566">2+</offsets></sup><offsets xml_i="17909" xml_f="17972" txt_i="11566" txt_f="11629">–o-dianisidine complex reacts with a standardized solution of H</offsets><sub><offsets xml_i="17977" xml_f="17978" txt_i="11629" txt_f="11630">2</offsets></sub><offsets xml_i="17984" xml_f="17985" txt_i="11630" txt_f="11631">O</offsets><sub><offsets xml_i="17990" xml_f="17991" txt_i="11631" txt_f="11632">2</offsets></sub><offsets xml_i="17997" xml_f="18056" txt_i="11632" txt_f="11691"> by a Fenton-type reaction, producing hydroxyl radicals (OH</offsets><sup><offsets xml_i="18061" xml_f="18062" txt_i="11691" txt_f="11692">∙</offsets></sup><offsets xml_i="18068" xml_f="18640" txt_i="11692" txt_f="12264">). These potent ROS oxidize the reduced colorless o-dianisidine molecules to yellow-brown colored dianisidyl radicals at low pH. Antioxidants in the sample suppress the oxidation reactions and color formation. This reaction can be monitored by spectrophotometry. The reaction rate is calibrated with Trolox (a water-soluble analogue of vitamin E, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) and was incorporated into Ilab 300 plus autoanalyser (Instrumentation Laboratory, Milan, Italy). The TAS value of the samples tested is expressed as mmolTrolox equiv./L.</offsets></p><p><offsets xml_i="18647" xml_f="18717" txt_i="12265" txt_f="12335">Total oxidant status (TOS) was determined according to Erels' method [</offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="18749" xml_f="18751" txt_i="12335" txt_f="12337">20</offsets></xref><offsets xml_i="18758" xml_f="19133" txt_i="12337" txt_f="12712">]. This assay is based on the oxidation of ferrous ion to ferric ion in the presence of various oxidant species in serum. The ferric ion makes a colored complex with xylenol orange in an acidic medium. The color intensity, which can be measured spectrophotometrically, is related to the total amount of oxidant molecules present in the sample. The assay was calibrated with H</offsets><sub><offsets xml_i="19138" xml_f="19139" txt_i="12712" txt_f="12713">2</offsets></sub><offsets xml_i="19145" xml_f="19146" txt_i="12713" txt_f="12714">O</offsets><sub><offsets xml_i="19151" xml_f="19152" txt_i="12714" txt_f="12715">2</offsets></sub><offsets xml_i="19158" xml_f="19341" txt_i="12715" txt_f="12898"> and incorporated into Ilab 300 plus autoanalyser (Instrumentation Laboratory, Milan, Italy). The results are expressed in terms of micromolar hydrogen peroxide equivalent per liter (</offsets><italic><offsets xml_i="19349" xml_f="19350" txt_i="12898" txt_f="12899">μ</offsets></italic><offsets xml_i="19359" xml_f="19363" txt_i="12899" txt_f="12903">molH</offsets><sub><offsets xml_i="19368" xml_f="19369" txt_i="12903" txt_f="12904">2</offsets></sub><offsets xml_i="19375" xml_f="19376" txt_i="12904" txt_f="12905">O</offsets><sub><offsets xml_i="19381" xml_f="19382" txt_i="12905" txt_f="12906">2</offsets></sub><offsets xml_i="19388" xml_f="19399" txt_i="12906" txt_f="12917"> equiv./L).</offsets></p><p><offsets xml_i="19406" xml_f="19500" txt_i="12918" txt_f="13012">Prooxidant-antioxidant balance (PAB) was measured according to a previously published method [</offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="19532" xml_f="19534" txt_i="13012" txt_f="13014">21</offsets></xref><offsets xml_i="19541" xml_f="20009" txt_i="13014" txt_f="13482">]. This method is based on two different oxidation-reduction reactions which take place simultaneously. In enzymatic reaction, the chromogen TMB is oxidized to a colored cation by peroxides, and in the chemical reaction, the colored TMB cation is reduced to a colorless compound by antioxidants. The photometric absorbance is then compared with the absorbance given by a series of standard solutions that are made by mixing varying proportions (0–100%) of 250 mmol/L H</offsets><sub><offsets xml_i="20014" xml_f="20015" txt_i="13482" txt_f="13483">2</offsets></sub><offsets xml_i="20021" xml_f="20022" txt_i="13483" txt_f="13484">O</offsets><sub><offsets xml_i="20027" xml_f="20028" txt_i="13484" txt_f="13485">2</offsets></sub><offsets xml_i="20034" xml_f="20282" txt_i="13485" txt_f="13733">, as a representative of hydroperoxides, which is an indicator of total oxidant status, with 3 mmol/L uric acid (in 10 mmol/L NaOH), as a representative of the antioxidant capacity. This photometric comparison was carried out using an ELISA reader.</offsets></p><p><offsets xml_i="20289" xml_f="20375" txt_i="13734" txt_f="13820">TMB powder (60 mg) was dissolved in 10 mL of DMSO. For preparation of TMB cation, 400 </offsets><italic><offsets xml_i="20383" xml_f="20384" txt_i="13820" txt_f="13821">μ</offsets></italic><offsets xml_i="20393" xml_f="20474" txt_i="13821" txt_f="13902">L of TMB/DMSO was added in 20 mL of acetate buffer (0.05 M, pH 4.5), and then 70 </offsets><italic><offsets xml_i="20482" xml_f="20483" txt_i="13902" txt_f="13903">μ</offsets></italic><offsets xml_i="20492" xml_f="20791" txt_i="13903" txt_f="14202">L of fresh chloramine T (100 mM) solution in distilled water was added. The mixture was incubated in a dark place for 2 hr at room temperature, after which 25 units of peroxidase enzyme solution were added into 20 mL TMB cation, dispensed in 1 mL, and put at −20°C. To prepare the TMB solution, 200 </offsets><italic><offsets xml_i="20799" xml_f="20800" txt_i="14202" txt_f="14203">μ</offsets></italic><offsets xml_i="20809" xml_f="21089" txt_i="14203" txt_f="14483">L of TMB/DMSO was added into 10 mL of acetate buffer (0.05 M, pH 5.8). The working solution was prepared by mixing 1 mL of TMB cation with 10 mL of TMB solution. The mixture was incubated for 2 min at room temperature, in a dark place, and it was used immediately. The sample (10 </offsets><italic><offsets xml_i="21097" xml_f="21098" txt_i="14483" txt_f="14484">μ</offsets></italic><offsets xml_i="21107" xml_f="21168" txt_i="14484" txt_f="14545">L), standard, or blank (distilled water) were mixed with 200 </offsets><italic><offsets xml_i="21176" xml_f="21177" txt_i="14545" txt_f="14546">μ</offsets></italic><offsets xml_i="21186" xml_f="21338" txt_i="14546" txt_f="14698">L of working solution, in each well of a 96-well plate, which was then incubated in a dark place at 37°C for 12 min. At the end of incubation time, 100 </offsets><italic><offsets xml_i="21346" xml_f="21347" txt_i="14698" txt_f="14699">μ</offsets></italic><offsets xml_i="21356" xml_f="21771" txt_i="14699" txt_f="15114">L of 2N HCl was added into each well and measured in ELISA reader at 450 nm, with a reference wavelength of 620 or 570 nm (ELx800 Absorbance Microplate Reader, Biotek, Winooski, USA). A standard curve was provided from the values relative to the standard samples. The PAB values of the unknown samples were calculated using the standard curve and expressed in arbitrary HK units, which represent the percentage of H</offsets><sub><offsets xml_i="21776" xml_f="21777" txt_i="15114" txt_f="15115">2</offsets></sub><offsets xml_i="21783" xml_f="21784" txt_i="15115" txt_f="15116">O</offsets><sub><offsets xml_i="21789" xml_f="21790" txt_i="15116" txt_f="15117">2</offsets></sub><offsets xml_i="21796" xml_f="21835" txt_i="15117" txt_f="15156"> in standard solution, multiplied by 6.</offsets></p></sec><sec id="sec2.6"><title><offsets xml_i="21869" xml_f="21914" txt_i="15158" txt_f="15203">2.6. Hematological and Biochemical Parameters</offsets></title><p><offsets xml_i="21925" xml_f="23058" txt_i="15204" txt_f="16337">Hematological analysis was performed in the blood samples collected into K-EDTA tubes (Greiner Bio-one, Kremsmünster, Austria), using an automated hematology analyzer Cell-Dyn 3700 (Abbott Diagnostics, Illinois, USA). To examine biochemical parameters, blood samples were drawn from an antecubital vein into sample tube with serum separator gel (Greiner Bio-one, Kremsmünster, Austria) and then left to coagulate for 30 min to separate the serum, and the obtained samples were stored at −80°C for later analysis. The following items were included in the general biochemical examination: aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), lactate dehydrogenase (LDH), uric acid (UA), creatinine (Cre), high sensitivity C-reactive protein (hs-CRP), total cholesterol (CHOL), HDL cholesterol (HDL-C), and triglycerides (TG). Biochemical analysis was performed using an ILab 300 Plus autoanalyser (Instrumentation Laboratory, Milan, Italy) employing commercial kits (Bioanalytica, Belgrade, Serbia). The concentration of LDL cholesterol (LDL-C) was calculated using the formula of Friedewald et al. [</offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="23090" xml_f="23092" txt_i="16337" txt_f="16339">22</offsets></xref><offsets xml_i="23099" xml_f="23101" txt_i="16339" txt_f="16341">].</offsets></p></sec><sec id="sec2.7"><title><offsets xml_i="23135" xml_f="23160" txt_i="16343" txt_f="16368">2.7. Statistical Analysis</offsets></title><p><offsets xml_i="23171" xml_f="23714" txt_i="16369" txt_f="16912">Statistical analyses were performed using the PASW Statistics version 18.0 and MedCalc (version 11.4 Software, Belgium) software. All data were assessed for normality (Kolmogorov-Smirnov tests). The results are expressed in terms of mean values and standard error (SE) for normally distributed variables. Where distribution differed from a normal distribution, geometric means and 95% confidence intervals were given. Subjects' baseline characteristics and nutritional parameters between treatment groups were compared using independent-sample</offsets><italic><offsets xml_i="23722" xml_f="23724" txt_i="16912" txt_f="16914"> t</offsets></italic><offsets xml_i="23733" xml_f="23951" txt_i="16914" txt_f="17132">-test. The effects of supplementation and training were analyzed by two-way analysis of variance (ANOVA) with repeated measures to test for the two main effects and for the interaction between them. When a significant </offsets><italic><offsets xml_i="23959" xml_f="23960" txt_i="17132" txt_f="17133">p</offsets></italic><offsets xml_i="23969" xml_f="24000" txt_i="17133" txt_f="17164"> value was obtained, Bonferroni</offsets><italic><offsets xml_i="24008" xml_f="24017" txt_i="17164" txt_f="17173"> post hoc</offsets></italic><offsets xml_i="24026" xml_f="24112" txt_i="17173" txt_f="17259"> comparison test was employed to determine the differences between groups. Two-tailed </offsets><italic><offsets xml_i="24120" xml_f="24121" txt_i="17259" txt_f="17260">p</offsets></italic><offsets xml_i="24130" xml_f="24387" txt_i="17260" txt_f="17517"> values are given throughout. Due to the fact that the distributions of sIgA absolute concentrations and secretion rate, AST, ALT, CK, and hs-CRP were skewed, logarithmic transformation of these values was performed before statistical comparisons were made.</offsets></p></sec></sec><sec id="sec3"><title><offsets xml_i="24425" xml_f="24435" txt_i="17520" txt_f="17530">3. Results</offsets></title><sec id="sec3.1"><title><offsets xml_i="24467" xml_f="24496" txt_i="17531" txt_f="17560">3.1. Subjects Characteristics</offsets></title><p><offsets xml_i="24507" xml_f="24607" txt_i="17561" txt_f="17661">Physical characteristics for the 40 soccer players randomized to Asx and P groups are summarized in </offsets><xref ref-type="table" rid="tab1"><offsets xml_i="24641" xml_f="24648" txt_i="17661" txt_f="17668">Table 1</offsets></xref><offsets xml_i="24655" xml_f="24751" txt_i="17668" txt_f="17764">. No significant differences were found between groups according to age, body composition, or VO</offsets><sub><offsets xml_i="24756" xml_f="24760" txt_i="17764" txt_f="17768">2max</offsets></sub><offsets xml_i="24766" xml_f="24768" txt_i="17768" txt_f="17770"> (</offsets><italic><offsets xml_i="24776" xml_f="24777" txt_i="17770" txt_f="17771">p</offsets></italic><offsets xml_i="24786" xml_f="24797" txt_i="17771" txt_f="17779"> &gt; 0.05,</offsets><italic><offsets xml_i="24805" xml_f="24807" txt_i="17779" txt_f="17781"> t</offsets></italic><offsets xml_i="24816" xml_f="24823" txt_i="17781" txt_f="17788">-test).</offsets></p><p><offsets xml_i="24830" xml_f="24991" txt_i="17789" txt_f="17950">According to 4-day food records analysis using CRON-O-Meter v0.9.6 software, estimated daily energy and nutrient intake in two experimental groups were similar (</offsets><italic><offsets xml_i="24999" xml_f="25000" txt_i="17950" txt_f="17951">p</offsets></italic><offsets xml_i="25009" xml_f="25022" txt_i="17951" txt_f="17961"> &gt; 0.05), </offsets><xref ref-type="table" rid="tab2"><offsets xml_i="25056" xml_f="25063" txt_i="17961" txt_f="17968">Table 2</offsets></xref><offsets xml_i="25070" xml_f="25071" txt_i="17968" txt_f="17969">.</offsets></p></sec><sec id="sec3.2"><title><offsets xml_i="25105" xml_f="25172" txt_i="17971" txt_f="18038">3.2. Salivary Flow, sIgA Absolute Concentration, and Secretion Rate</offsets></title><p><offsets xml_i="25183" xml_f="25256" txt_i="18039" txt_f="18112">Salivary flow measurement was unaffected by training or supplementation (</offsets><italic><offsets xml_i="25264" xml_f="25265" txt_i="18112" txt_f="18113">p</offsets></italic><offsets xml_i="25274" xml_f="25369" txt_i="18113" txt_f="18205"> &gt; 0.05). The obtained values were unchanged after 90 days of training and supplementation (</offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="25401" xml_f="25412" txt_i="18205" txt_f="18216">Figure 1(a)</offsets></xref><offsets xml_i="25419" xml_f="25421" txt_i="18216" txt_f="18218">).</offsets></p><p><offsets xml_i="25428" xml_f="25525" txt_i="18219" txt_f="18316">ANOVA repeated measures showed a significant interaction effect of supplementation and training (</offsets><italic><offsets xml_i="25533" xml_f="25534" txt_i="18316" txt_f="18317">F</offsets></italic><offsets xml_i="25543" xml_f="25553" txt_i="18317" txt_f="18327"> = 6.221, </offsets><italic><offsets xml_i="25561" xml_f="25562" txt_i="18327" txt_f="18328">p</offsets></italic><offsets xml_i="25571" xml_f="25649" txt_i="18328" txt_f="18403"> &lt; 0.05) on sIgA absolute concentration as well as on sIgA secretion rate (</offsets><italic><offsets xml_i="25657" xml_f="25658" txt_i="18403" txt_f="18404">F</offsets></italic><offsets xml_i="25667" xml_f="25677" txt_i="18404" txt_f="18414"> = 4.608, </offsets><italic><offsets xml_i="25685" xml_f="25686" txt_i="18414" txt_f="18415">p</offsets></italic><offsets xml_i="25695" xml_f="25716" txt_i="18415" txt_f="18433"> &lt; 0.05) (Figures </offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="25748" xml_f="25752" txt_i="18433" txt_f="18437">1(b)</offsets></xref><offsets xml_i="25759" xml_f="25764" txt_i="18437" txt_f="18442"> and </offsets><xref ref-type="fig" rid="fig1"><offsets xml_i="25796" xml_f="25800" txt_i="18442" txt_f="18446">1(c)</offsets></xref><offsets xml_i="25807" xml_f="25809" txt_i="18446" txt_f="18448">).</offsets><italic><offsets xml_i="25817" xml_f="25826" txt_i="18448" txt_f="18457"> Post hoc</offsets></italic><offsets xml_i="25835" xml_f="25999" txt_i="18457" txt_f="18621"> comparison revealed a significant increase of sIgA absolute concentration and secretion rate in supplemented group after 90 days when compared to baseline values (</offsets><italic><offsets xml_i="26007" xml_f="26008" txt_i="18621" txt_f="18622">p</offsets></italic><offsets xml_i="26017" xml_f="26081" txt_i="18622" txt_f="18683"> &lt; 0.05), while there were no significant changes in P group.</offsets></p></sec><sec id="sec3.3"><title><offsets xml_i="26115" xml_f="26143" txt_i="18685" txt_f="18713">3.3. Oxidative Stress Status</offsets></title><p><offsets xml_i="26154" xml_f="26193" txt_i="18714" txt_f="18753">Oxidative stress status is reported in </offsets><xref ref-type="table" rid="tab3"><offsets xml_i="26227" xml_f="26234" txt_i="18753" txt_f="18760">Table 3</offsets></xref><offsets xml_i="26241" xml_f="26356" txt_i="18760" txt_f="18875">. Regular soccer training had a significant effect on TOS, regardless of supplementation (main effect of training, </offsets><italic><offsets xml_i="26364" xml_f="26365" txt_i="18875" txt_f="18876">F</offsets></italic><offsets xml_i="26374" xml_f="26386" txt_i="18876" txt_f="18888"> = 108.678, </offsets><italic><offsets xml_i="26394" xml_f="26395" txt_i="18888" txt_f="18889">p</offsets></italic><offsets xml_i="26404" xml_f="26608" txt_i="18889" txt_f="19090"> &lt; 0.001). TOS decreased in both, the supplemented and the P group, after 90 days of regular training in comparison to baseline values. Basal TAS was unaffected by soccer training and supplementation (</offsets><italic><offsets xml_i="26616" xml_f="26617" txt_i="19090" txt_f="19091">p</offsets></italic><offsets xml_i="26626" xml_f="26792" txt_i="19091" txt_f="19254"> &gt; 0.05). There was a significant decrease in PAB in Asx group after 90 days in comparison to baseline values (interaction effect of supplementation and training: </offsets><italic><offsets xml_i="26800" xml_f="26801" txt_i="19254" txt_f="19255">F</offsets></italic><offsets xml_i="26810" xml_f="26821" txt_i="19255" txt_f="19266"> = 25.371, </offsets><italic><offsets xml_i="26829" xml_f="26830" txt_i="19266" txt_f="19267">p</offsets></italic><offsets xml_i="26839" xml_f="26876" txt_i="19267" txt_f="19301"> &lt; 0.05; main effect of training: </offsets><italic><offsets xml_i="26884" xml_f="26885" txt_i="19301" txt_f="19302">F</offsets></italic><offsets xml_i="26894" xml_f="26904" txt_i="19302" txt_f="19312"> = 4.205, </offsets><italic><offsets xml_i="26912" xml_f="26913" txt_i="19312" txt_f="19313">p</offsets></italic><offsets xml_i="26922" xml_f="27037" txt_i="19313" txt_f="19425"> &lt; 0.001), as a result of continuous training and supplementation. No significant changes were found in P group.</offsets></p></sec><sec id="sec3.4"><title><offsets xml_i="27071" xml_f="27100" txt_i="19427" txt_f="19456">3.4. Hematological Parameters</offsets></title><p><offsets xml_i="27111" xml_f="27286" txt_i="19457" txt_f="19632">After 90 days of training and supplementation, ANOVA analysis showed a significant increase in leukocyte count in P group (interaction effect of supplementation and training: </offsets><italic><offsets xml_i="27294" xml_f="27295" txt_i="19632" txt_f="19633">F</offsets></italic><offsets xml_i="27304" xml_f="27314" txt_i="19633" txt_f="19643"> = 4.528, </offsets><italic><offsets xml_i="27322" xml_f="27323" txt_i="19643" txt_f="19644">p</offsets></italic><offsets xml_i="27332" xml_f="27369" txt_i="19644" txt_f="19678"> &lt; 0.05; main effect of training: </offsets><italic><offsets xml_i="27377" xml_f="27378" txt_i="19678" txt_f="19679">F</offsets></italic><offsets xml_i="27387" xml_f="27397" txt_i="19679" txt_f="19689"> = 3.989, </offsets><italic><offsets xml_i="27405" xml_f="27406" txt_i="19689" txt_f="19690">p</offsets></italic><offsets xml_i="27415" xml_f="27465" txt_i="19690" txt_f="19737"> &lt; 0.05) but not in Asx group, as presented in </offsets><xref ref-type="fig" rid="fig2"><offsets xml_i="27497" xml_f="27505" txt_i="19737" txt_f="19745">Figure 2</offsets></xref><offsets xml_i="27512" xml_f="27670" txt_i="19745" txt_f="19903">. There was a significant increase in neutrophil count in P group after 90 days of observational period compared to baseline values (main effect of training: </offsets><italic><offsets xml_i="27678" xml_f="27679" txt_i="19903" txt_f="19904">F</offsets></italic><offsets xml_i="27688" xml_f="27698" txt_i="19904" txt_f="19914"> = 4.875, </offsets><italic><offsets xml_i="27706" xml_f="27707" txt_i="19914" txt_f="19915">p</offsets></italic><offsets xml_i="27716" xml_f="27783" txt_i="19915" txt_f="19979"> &lt; 0.01). These changes were not detected in supplemented group.</offsets></p></sec><sec id="sec3.5"><title><offsets xml_i="27817" xml_f="27844" txt_i="19981" txt_f="20008">3.5. Biochemical Parameters</offsets></title><p><offsets xml_i="27855" xml_f="27891" txt_i="20009" txt_f="20045">Biochemical parameters are shown in </offsets><xref ref-type="table" rid="tab4"><offsets xml_i="27925" xml_f="27932" txt_i="20045" txt_f="20052">Table 4</offsets></xref><offsets xml_i="27939" xml_f="28002" txt_i="20052" txt_f="20115">. ANOVA revealed a significant main effect of training on AST (</offsets><italic><offsets xml_i="28010" xml_f="28011" txt_i="20115" txt_f="20116">F</offsets></italic><offsets xml_i="28020" xml_f="28031" txt_i="20116" txt_f="20127"> = 57.029, </offsets><italic><offsets xml_i="28039" xml_f="28040" txt_i="20127" txt_f="20128">p</offsets></italic><offsets xml_i="28049" xml_f="28067" txt_i="20128" txt_f="20143"> &lt; 0.001), CK (</offsets><italic><offsets xml_i="28075" xml_f="28076" txt_i="20143" txt_f="20144">F</offsets></italic><offsets xml_i="28085" xml_f="28096" txt_i="20144" txt_f="20155"> = 29.000, </offsets><italic><offsets xml_i="28104" xml_f="28105" txt_i="20155" txt_f="20156">p</offsets></italic><offsets xml_i="28114" xml_f="28136" txt_i="20156" txt_f="20175"> &lt; 0.01), and LDH (</offsets><italic><offsets xml_i="28144" xml_f="28145" txt_i="20175" txt_f="20176">F</offsets></italic><offsets xml_i="28154" xml_f="28165" txt_i="20176" txt_f="20187"> = 87.641, </offsets><italic><offsets xml_i="28173" xml_f="28174" txt_i="20187" txt_f="20188">p</offsets></italic><offsets xml_i="28183" xml_f="28210" txt_i="20188" txt_f="20212"> &lt; 0.001) plasma levels.</offsets><italic><offsets xml_i="28218" xml_f="28227" txt_i="20212" txt_f="20221"> Post hoc</offsets></italic><offsets xml_i="28236" xml_f="28349" txt_i="20221" txt_f="20334"> comparison showed a significant decrease in CK activity in Asx group after 90 days compared to baseline values (</offsets><italic><offsets xml_i="28357" xml_f="28358" txt_i="20334" txt_f="20335">p</offsets></italic><offsets xml_i="28367" xml_f="28530" txt_i="20335" txt_f="20495"> &lt; 0.01), while a decrease in P group was not statistically significant. After 90 days of continuous training, AST and LDH decreased significantly in both Asx (</offsets><italic><offsets xml_i="28538" xml_f="28539" txt_i="20495" txt_f="20496">p</offsets></italic><offsets xml_i="28548" xml_f="28561" txt_i="20496" txt_f="20506"> &lt; 0.001, </offsets><italic><offsets xml_i="28569" xml_f="28570" txt_i="20506" txt_f="20507">p</offsets></italic><offsets xml_i="28579" xml_f="28611" txt_i="20507" txt_f="20536"> &lt; 0.01, resp.) and P group (</offsets><italic><offsets xml_i="28619" xml_f="28620" txt_i="20536" txt_f="20537">p</offsets></italic><offsets xml_i="28629" xml_f="28641" txt_i="20537" txt_f="20546"> &lt; 0.01, </offsets><italic><offsets xml_i="28649" xml_f="28650" txt_i="20546" txt_f="20547">p</offsets></italic><offsets xml_i="28659" xml_f="28757" txt_i="20547" txt_f="20642"> &lt; 0.5, resp.). In addition, a significant main effect of supplementation was observed on AST (</offsets><italic><offsets xml_i="28765" xml_f="28766" txt_i="20642" txt_f="20643">F</offsets></italic><offsets xml_i="28775" xml_f="28785" txt_i="20643" txt_f="20653"> = 3.979, </offsets><italic><offsets xml_i="28793" xml_f="28794" txt_i="20653" txt_f="20654">p</offsets></italic><offsets xml_i="28803" xml_f="28824" txt_i="20654" txt_f="20672"> &lt; 0.05) and LDH (</offsets><italic><offsets xml_i="28832" xml_f="28833" txt_i="20672" txt_f="20673">F</offsets></italic><offsets xml_i="28842" xml_f="28852" txt_i="20673" txt_f="20683"> = 3.995, </offsets><italic><offsets xml_i="28860" xml_f="28861" txt_i="20683" txt_f="20684">p</offsets></italic><offsets xml_i="28870" xml_f="28937" txt_i="20684" txt_f="20748"> &lt; 0.05) levels, with lower activity in Asx compared to P group.</offsets></p><p><offsets xml_i="28944" xml_f="29068" txt_i="20749" txt_f="20873">UA and Cre levels significantly decreased in both groups after 90 days of observational period (UA main effect of training, </offsets><italic><offsets xml_i="29076" xml_f="29077" txt_i="20873" txt_f="20874">F</offsets></italic><offsets xml_i="29086" xml_f="29096" txt_i="20874" txt_f="20884"> = 5.528, </offsets><italic><offsets xml_i="29104" xml_f="29105" txt_i="20884" txt_f="20885">p</offsets></italic><offsets xml_i="29114" xml_f="29155" txt_i="20885" txt_f="20923"> &lt; 0.05; Cre main effect of training, </offsets><italic><offsets xml_i="29163" xml_f="29164" txt_i="20923" txt_f="20924">F</offsets></italic><offsets xml_i="29173" xml_f="29183" txt_i="20924" txt_f="20934"> = 4.429, </offsets><italic><offsets xml_i="29191" xml_f="29192" txt_i="20934" txt_f="20935">p</offsets></italic><offsets xml_i="29201" xml_f="29304" txt_i="20935" txt_f="21035"> &lt; 0.05). ANOVA analysis also showed a significant supplementation and training interaction effect (</offsets><italic><offsets xml_i="29312" xml_f="29313" txt_i="21035" txt_f="21036">F</offsets></italic><offsets xml_i="29322" xml_f="29332" txt_i="21036" txt_f="21046"> = 4.050, </offsets><italic><offsets xml_i="29340" xml_f="29341" txt_i="21046" txt_f="21047">p</offsets></italic><offsets xml_i="29350" xml_f="29632" txt_i="21047" txt_f="21329"> = 0.05) on hs-CRP levels. Namely, after 90 days of regular soccer training, a 57% increase in hs-CRP levels may be observed in P group, but not in the Asx group. Analysis of lipid profile revealed no effect of training, supplementation, or supplementation and training interaction.</offsets></p></sec></sec><sec id="sec4"><title><offsets xml_i="29670" xml_f="29683" txt_i="21332" txt_f="21345">4. Discussion</offsets></title><p><offsets xml_i="29694" xml_f="30105" txt_i="21346" txt_f="21757">The main finding of the present study was the rise of sIgA levels at rest after 90 days of Asx supplementation which was accompanied with a decrease in prooxidant-antioxidant balance (PAB). Also, the increase in neutrophil count and hs-CRP level recorded in placebo group was not apparent in supplemented group, indicating a significant blunting of the systemic inflammatory response in the subjects taking Asx.</offsets></p><p><offsets xml_i="30112" xml_f="30386" txt_i="21758" txt_f="22032">The observed increase in sIgA levels after supplementation could indicate the effect of Asx on sIgA synthesis. Previous studies reported modulatory actions of Asx on humoral immune response such as induced production of polyclonal antibodies G and M in murine spleen cells [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="30418" xml_f="30420" txt_i="22032" txt_f="22034">14</offsets></xref><offsets xml_i="30427" xml_f="30481" txt_i="22034" txt_f="22088">], increased IgG and IgM production in cats and dogs [</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="30513" xml_f="30515" txt_i="22088" txt_f="22090">16</offsets></xref><offsets xml_i="30522" xml_f="30524" txt_i="22090" txt_f="22092">, </offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="30556" xml_f="30558" txt_i="22092" txt_f="22094">17</offsets></xref><offsets xml_i="30565" xml_f="30624" txt_i="22094" txt_f="22153">], partially restored humoral immune response in old mice [</offsets><xref rid="B23" ref-type="bibr"><offsets xml_i="30656" xml_f="30658" txt_i="22153" txt_f="22155">23</offsets></xref><offsets xml_i="30665" xml_f="30764" txt_i="22155" txt_f="22254">], and enhanced immunoglobulin production in response to T-dependent stimuli in human blood cells [</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="30796" xml_f="30798" txt_i="22254" txt_f="22256">15</offsets></xref><offsets xml_i="30805" xml_f="30941" txt_i="22256" txt_f="22392">]. Although the mechanism of Asx action was not known, it was suggested that it enhanced the antibody production through release of IL-1</offsets><italic><offsets xml_i="30949" xml_f="30950" txt_i="22392" txt_f="22393">α</offsets></italic><offsets xml_i="30959" xml_f="30961" txt_i="22393" txt_f="22395"> [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="30993" xml_f="30995" txt_i="22395" txt_f="22397">14</offsets></xref><offsets xml_i="31002" xml_f="31073" txt_i="22397" txt_f="22468">], which is one of major regulating factors in B cell differentiation [</offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="31105" xml_f="31107" txt_i="22468" txt_f="22470">24</offsets></xref><offsets xml_i="31114" xml_f="31240" txt_i="22470" txt_f="22596">]. The beneficial effect of Asx on mucosal immunity, also found in our study, might be explained by its antioxidant activity [</offsets><xref rid="B25" ref-type="bibr"><offsets xml_i="31272" xml_f="31274" txt_i="22596" txt_f="22598">25</offsets></xref><offsets xml_i="31281" xml_f="31605" txt_i="22598" txt_f="22922">]. Immune cells are particularly sensitive to oxidative stress due to a high percentage of polyunsaturated fatty acids in their plasma membranes, and they generally produce more oxidative products. Overproduction of ROS can tip the oxidant/antioxidant balance, resulting in destruction of cell membranes, proteins, and DNA [</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="31637" xml_f="31639" txt_i="22922" txt_f="22924">13</offsets></xref><offsets xml_i="31646" xml_f="31786" txt_i="22924" txt_f="23064">]. ROS overproduction during physical activity might also inhibit locomotor and bactericidal activity of neutrophils, as shown in study of [</offsets><xref rid="B26" ref-type="bibr"><offsets xml_i="31818" xml_f="31820" txt_i="23064" txt_f="23066">26</offsets></xref></p><p><offsets xml_i="31834" xml_f="32037" txt_i="23067" txt_f="23270">Therefore, under conditions of increased oxidative stress (e.g., during disease states or physical activity), dietary antioxidants become critical in maintaining a desirable oxidant/antioxidant balance [</offsets><xref rid="B27" ref-type="bibr"><offsets xml_i="32069" xml_f="32071" txt_i="23270" txt_f="23272">27</offsets></xref><offsets xml_i="32078" xml_f="32500" txt_i="23272" txt_f="23694">]. In our study, oxidative stress (measured by TOS) was significantly reduced after 90 days of regular training in both groups of soccer players, probably due to an upregulation in the body's enzymatic AO defense system. However, nonenzymatic antioxidants presented in plasma (measured by TAS) were not affected by training or supplementation during the observational period, which is in accordance with previous studies [</offsets><xref rid="B28" ref-type="bibr"><offsets xml_i="32532" xml_f="32534" txt_i="23694" txt_f="23696">28</offsets></xref><offsets xml_i="32541" xml_f="32543" txt_i="23696" txt_f="23698">, </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="32575" xml_f="32577" txt_i="23698" txt_f="23700">29</offsets></xref><offsets xml_i="32584" xml_f="32836" txt_i="23700" txt_f="23952">]. Antioxidants are known to work synergistically to defend against oxidant production. In other words, when one AO nutrient is lacking in particular period of time, another could substitute it or it may be regenerated by another that is in abundance [</offsets><xref rid="B30" ref-type="bibr"><offsets xml_i="32868" xml_f="32870" txt_i="23952" txt_f="23954">30</offsets></xref><offsets xml_i="32877" xml_f="33271" txt_i="23954" txt_f="24348">]. This may be the reason why no changes in TAS levels at rest were observed during 90 days of regular training and supplementation. Mobilization of tissue antioxidants into the plasma in order to maintain the AO status and to protect the body against ROS may also explain, in part, why no significant changes in TAS levels at rest were observed in response to training or Asx supplementation [</offsets><xref rid="B31" ref-type="bibr"><offsets xml_i="33303" xml_f="33305" txt_i="24348" txt_f="24350">31</offsets></xref><offsets xml_i="33312" xml_f="33447" txt_i="24350" txt_f="24485">]. These results suggest that human organism has very potent mechanisms which protect cells against free radicals and oxidative stress.</offsets></p><p><offsets xml_i="33454" xml_f="33982" txt_i="24486" txt_f="25014">However, we showed that Asx supplementation resulted in decreased prooxidant-antioxidant balance (PAB) during regular competitive season in young soccer players. Therefore, we believe that deleterious effects caused by the excess of ROS produced during physical activity can be additionally attenuated by the Asx. Asx induced a better redox balance favoring all cellular functions which depend on adequate amounts of ROS, thereby supporting the mucosal immune system. Our finding is in accordance with the study of Park et al. [</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="34014" xml_f="34016" txt_i="25014" txt_f="25016">18</offsets></xref><offsets xml_i="34023" xml_f="34231" txt_i="25016" txt_f="25224">] who examined the possible immune-enhancing, AO, and anti-inflammatory activity of Asx in healthy women and showed that Asx could decrease a DNA oxidative damage and inflammation and enhance immune response.</offsets></p><p><offsets xml_i="34238" xml_f="34488" txt_i="25225" txt_f="25475">The magnitude of muscle damage, evaluated by CK and LDH in our study, was reduced significantly over the observational period, probably by adaptation and conditioning of the muscle through regular training, as shown previously by Powers and Jackson [</offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="34520" xml_f="34522" txt_i="25475" txt_f="25477">32</offsets></xref><offsets xml_i="34529" xml_f="34867" txt_i="25477" txt_f="25815">]. Asx supplementation additionally attenuated exercise-induced muscle damage. Although muscle damage represents a direct consequence of exercise injury which mechanically disrupts muscle myofibrils, tissue damage associated to exercise-induced free radical production and subsequent oxidative stress was also suggested by Davies et al. [</offsets><xref rid="B33" ref-type="bibr"><offsets xml_i="34899" xml_f="34901" txt_i="25815" txt_f="25817">33</offsets></xref><offsets xml_i="34908" xml_f="35265" txt_i="25817" txt_f="26174">]. It can be hypothesized that Asx protects the cell membranes against free radicals generated during heavy exercise, thus preserving the functionality of muscle cells. The unsaturated polygene chain of Asx could trap radicals in the membrane, while the terminal rings scavenge radicals both at the surface and in the interior of the phospholipid membrane [</offsets><xref rid="B34" ref-type="bibr"><offsets xml_i="35297" xml_f="35299" txt_i="26174" txt_f="26176">34</offsets></xref><offsets xml_i="35306" xml_f="35496" txt_i="26176" txt_f="26366">]. Similar results were obtained in animal experiments, reporting that Asx attenuated oxidative damage of lipids and DNA in gastrocnemius and heart as well as the leakage of CK into plasma [</offsets><xref rid="B35" ref-type="bibr"><offsets xml_i="35528" xml_f="35530" txt_i="26366" txt_f="26368">35</offsets></xref><offsets xml_i="35537" xml_f="35539" txt_i="26368" txt_f="26370">].</offsets></p><p><offsets xml_i="35546" xml_f="35944" txt_i="26371" txt_f="26769">In this study, regular soccer training during the competitive season led to certain changes in leukocytes count only in placebo group. Over the time, total leukocytes count, neutrophil count, and hs-CRP levels had increased. The observed elevation in hs-CRP due to the regular intensive training was similar to the levels that have been associated with increased risk of coronary vascular disease [</offsets><xref rid="B36" ref-type="bibr"><offsets xml_i="35976" xml_f="35978" txt_i="26769" txt_f="26771">36</offsets></xref><offsets xml_i="35985" xml_f="36270" txt_i="26771" txt_f="27056">]. These changes were not detected in supplemented group, which further supports the notion that Asx, as dietary supplement, has the ability to suppress minor inflammatory events induced by training. Anti-inflammatory action of Asx was previously detected in human and animal studies [</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="36302" xml_f="36304" txt_i="27056" txt_f="27058">16</offsets></xref><offsets xml_i="36311" xml_f="36313" txt_i="27058" txt_f="27060">, </offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="36345" xml_f="36347" txt_i="27060" txt_f="27062">17</offsets></xref><offsets xml_i="36354" xml_f="36356" txt_i="27062" txt_f="27064">, </offsets><xref rid="B35" ref-type="bibr"><offsets xml_i="36388" xml_f="36390" txt_i="27064" txt_f="27066">35</offsets></xref><offsets xml_i="36397" xml_f="36399" txt_i="27066" txt_f="27068">].</offsets></p><p><offsets xml_i="36406" xml_f="36689" txt_i="27069" txt_f="27352">Evidence suggests that Asx has potential health-promoting effects in prevention and treatment of various diseases, such as chronic inflammatory diseases, metabolic syndrome, diabetes, cardiovascular disease, neurodegenerative diseases, exercise-induced fatigue, or male infertility [</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="36721" xml_f="36723" txt_i="27352" txt_f="27354">13</offsets></xref><offsets xml_i="36730" xml_f="37067" txt_i="27354" txt_f="27691">], which likely involves AO mechanisms and decreased production of inflammatory mediators and cytokines. It is already known that physiologic stress, induced by prolonged and intensive physical activity, is reflected by transient, yet significant immune system perturbations, along with oxidative stress, muscle injury, and inflammation.</offsets></p></sec><sec id="sec5"><title><offsets xml_i="37099" xml_f="37113" txt_i="27693" txt_f="27707">5. Conclusions</offsets></title><p><offsets xml_i="37124" xml_f="37907" txt_i="27708" txt_f="28491">According to the results presented in this study, Asx supplementation improved sIgA response and attenuated muscle damage, probably due to restoring redox balance, thus preventing inflammation induced by rigorous physical training. Although our study focused on narrow population regarding the age, gender, and life style, nevertheless, it showed the modulating effects of Asx on the examined parameters. Our findings also indicate that Asx could show significant physiologic modulation in other individuals with mucosal immunity impairment or under conditions of increased oxidative stress and inflammation. Although the currently available data and recent findings are very encouraging, more extensive, well-controlled clinical trials are suggested for other threatened categories.</offsets></p></sec></body><back><ack><title>Acknowledgments</title><p>This work was financially supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grants III46001 and III41027). The authors wish to thank Dr. Ljiljana Dimitrijevic for the assistance in the data interpretation and writing of the paper.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>URTI:</term><def><p>Upper respiratory tract infection</p></def></def-item><def-item><term>DTH:</term><def><p>Delayed-type hypersensitivity</p></def></def-item><def-item><term>BMI:</term><def><p>Body mass index</p></def></def-item><def-item><term>ELISA:</term><def><p>Enzyme-linked immunosorbent assay</p></def></def-item><def-item><term>TAS:</term><def><p>Total antioxidant status</p></def></def-item><def-item><term>TOS:</term><def><p>Total oxidant status</p></def></def-item><def-item><term>PAB:</term><def><p>Prooxidant-antioxidant balance</p></def></def-item><def-item><term>AST:</term><def><p>Aminotransferase</p></def></def-item><def-item><term>ALT:</term><def><p>Alanine aminotransferase</p></def></def-item><def-item><term>CK:</term><def><p>Creatine kinase</p></def></def-item><def-item><term>LDH:</term><def><p>Lactate dehydrogenase</p></def></def-item><def-item><term>UA:</term><def><p>Uric acid</p></def></def-item><def-item><term>Cre:</term><def><p>Creatinine</p></def></def-item><def-item><term>hs-CRP:</term><def><p>High sensitivity C-reactive protein</p></def></def-item><def-item><term>CHOL:</term><def><p>Total cholesterol</p></def></def-item><def-item><term>HDL-C:</term><def><p>HDL cholesterol</p></def></def-item><def-item><term>TG:</term><def><p>Triglycerides</p></def></def-item><def-item><term>LDL-C:</term><def><p>LDL cholesterol</p></def></def-item><def-item><term>SE:</term><def><p>Standard error</p></def></def-item><def-item><term>ROS:</term><def><p>Reactive oxygen species</p></def></def-item><def-item><term>AMP:</term><def><p>Adenosine monophosphate</p></def></def-item><def-item><term>ATP:</term><def><p>Adenosine triphosphate.</p></def></def-item></def-list></glossary><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declared that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higuera-Ciapara</surname><given-names>I.</given-names></name><name><surname>Félix-Valenzuela</surname><given-names>L.</given-names></name><name><surname>Goycoolea</surname><given-names>F. M.</given-names></name></person-group><article-title>Astaxanthin: a review of its chemistry and applications</article-title><source><italic>Critical Reviews in Food Science and Nutrition</italic></source><year>2006</year><volume>46</volume><issue>2</issue><fpage>185</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1080/10408690590957188</pub-id><pub-id pub-id-type="other">2-s2.0-33644615637</pub-id><pub-id pub-id-type="pmid">16431409</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>G.</given-names></name><name><surname>Goto</surname><given-names>H.</given-names></name><name><surname>Oda</surname><given-names>S.</given-names></name><name><surname>Sankawa</surname><given-names>U.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name><name><surname>Watanabe</surname><given-names>H.</given-names></name></person-group><article-title>Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats</article-title><source><italic>Biological and Pharmaceutical Bulletin</italic></source><year>2006</year><volume>29</volume><issue>4</issue><fpage>684</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.684</pub-id><pub-id pub-id-type="other">2-s2.0-33645543070</pub-id><pub-id pub-id-type="pmid">16595899</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidd</surname><given-names>P.</given-names></name></person-group><article-title>Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential</article-title><source><italic>Alternative Medicine Review</italic></source><year>2011</year><volume>16</volume><issue>4</issue><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="other">2-s2.0-84857404002</pub-id><pub-id pub-id-type="pmid">22214255</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacPherson</surname><given-names>A. J.</given-names></name><name><surname>McCoy</surname><given-names>K. D.</given-names></name><name><surname>Johansen</surname><given-names>F.-E.</given-names></name><name><surname>Brandtzaeg</surname><given-names>P.</given-names></name></person-group><article-title>The immune geography of IgA induction and function</article-title><source><italic>Mucosal Immunology</italic></source><year>2008</year><volume>1</volume><issue>1</issue><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/mi.2007.6</pub-id><pub-id pub-id-type="other">2-s2.0-42749092211</pub-id><pub-id pub-id-type="pmid">19079156</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macpherson</surname><given-names>A. J.</given-names></name><name><surname>Geuking</surname><given-names>M. B.</given-names></name><name><surname>McCoy</surname><given-names>K. D.</given-names></name></person-group><article-title>Homeland Security: IgA immunity at the frontiers of the body</article-title><source><italic>Trends in Immunology</italic></source><year>2012</year><volume>33</volume><issue>4</issue><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.it.2012.02.002</pub-id><pub-id pub-id-type="other">2-s2.0-84859164917</pub-id><pub-id pub-id-type="pmid">22410243</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackinnon</surname><given-names>L. T.</given-names></name></person-group><article-title>Immunoglobulin, antibody and exercise</article-title><source><italic>Exercise Immunology Review</italic></source><year>1996</year><volume>2</volume><fpage>1</fpage><lpage>35</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miletic</surname><given-names>I. D.</given-names></name><name><surname>Schiffman</surname><given-names>S. S.</given-names></name><name><surname>Miletic</surname><given-names>V. D.</given-names></name><name><surname>Sattely-Miller</surname><given-names>E. A.</given-names></name></person-group><article-title>Salivary IgA secretion rate in young and elderly persons</article-title><source><italic>Physiology &amp; Behavior</italic></source><year>1996</year><volume>60</volume><issue>1</issue><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/0031-9384(95)02161-2</pub-id><pub-id pub-id-type="other">2-s2.0-0030184252</pub-id><pub-id pub-id-type="pmid">8804670</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matos-Gomes</surname><given-names>N.</given-names></name><name><surname>Katsurayama</surname><given-names>M.</given-names></name><name><surname>Makimoto</surname><given-names>F. H.</given-names></name><etal></etal></person-group><article-title>Psychological stress and its influence on salivary flow rate, total protein concentration and IgA, IgG and IgM titers</article-title><source><italic>NeuroImmunoModulation</italic></source><year>2010</year><volume>17</volume><issue>6</issue><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1159/000292064</pub-id><pub-id pub-id-type="other">2-s2.0-77952836094</pub-id><pub-id pub-id-type="pmid">20516721</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cripps</surname><given-names>A. W.</given-names></name><name><surname>Otczyk</surname><given-names>D. C.</given-names></name><name><surname>Barker</surname><given-names>J.</given-names></name><name><surname>Lehmann</surname><given-names>D.</given-names></name><name><surname>Alpers</surname><given-names>M. P.</given-names></name></person-group><article-title>The relationship between undernutrition and humoral immune status in children with pneumonia in Papua New Guinea</article-title><source><italic>Papua and New Guinea Medical Journal</italic></source><year>2008</year><volume>51</volume><issue>3-4</issue><fpage>120</fpage><lpage>130</lpage><pub-id pub-id-type="other">2-s2.0-79952109509</pub-id><pub-id pub-id-type="pmid">21061943</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>M.</given-names></name><name><surname>Pyne</surname><given-names>D. B.</given-names></name></person-group><article-title>Special feature for the Olympics: effects of Exercise on the immune system: exercise effects on mucosal immunity</article-title><source><italic>Immunology and Cell Biology</italic></source><year>2000</year><volume>78</volume><issue>5</issue><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1711.2000.00956.x</pub-id><pub-id pub-id-type="other">2-s2.0-0034296285</pub-id><pub-id pub-id-type="pmid">11050537</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>M.</given-names></name><name><surname>McDonald</surname><given-names>W. A.</given-names></name><name><surname>Pyne</surname><given-names>D. B.</given-names></name><etal></etal></person-group><article-title>Salivary IgA levels and infection risk in elite swimmers</article-title><source><italic>Medicine &amp; Science in Sports &amp; Exercise</italic></source><year>1999</year><volume>31</volume><issue>1</issue><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1097/00005768-199901000-00012</pub-id><pub-id pub-id-type="other">2-s2.0-0032932369</pub-id><pub-id pub-id-type="pmid">9927012</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>D. C.</given-names></name><name><surname>Bishop</surname><given-names>N. C.</given-names></name></person-group><article-title>Nutritional strategies to counter stress to the immune system in athletes, with special reference to football</article-title><source><italic>Journal of Sports Sciences</italic></source><year>2006</year><volume>24</volume><issue>7</issue><fpage>763</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1080/02640410500482982</pub-id><pub-id pub-id-type="other">2-s2.0-33646394101</pub-id><pub-id pub-id-type="pmid">16766504</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J.-P.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>J.-H.</given-names></name></person-group><article-title>Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae</article-title><source><italic>Molecular Nutrition &amp; Food Research</italic></source><year>2011</year><volume>55</volume><issue>1</issue><fpage>150</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201000414</pub-id><pub-id pub-id-type="other">2-s2.0-78650923595</pub-id><pub-id pub-id-type="pmid">21207519</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okai</surname><given-names>Y.</given-names></name><name><surname>Higashi-Okai</surname><given-names>K.</given-names></name></person-group><article-title>Possible immonomodulating activities of carotenoids in in vitro cell culture experiments</article-title><source><italic>International Journal of Immunopharmacology</italic></source><year>1996</year><volume>18</volume><issue>12</issue><fpage>753</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/S0192-0561(97)85558-0</pub-id><pub-id pub-id-type="other">2-s2.0-0030299074</pub-id><pub-id pub-id-type="pmid">9172019</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyonouchi</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Tomita</surname><given-names>Y.</given-names></name><name><surname>Gross</surname><given-names>M. D.</given-names></name></person-group><article-title>Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen</article-title><source><italic>Journal of Nutrition</italic></source><year>1995</year><volume>125</volume><issue>10</issue><fpage>2483</fpage><lpage>2492</lpage><pub-id pub-id-type="other">2-s2.0-0028801281</pub-id><pub-id pub-id-type="pmid">7562082</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J. S.</given-names></name><name><surname>Mathison</surname><given-names>B. D.</given-names></name><name><surname>Hayek</surname><given-names>M. G.</given-names></name><name><surname>Massimino</surname><given-names>S.</given-names></name><name><surname>Reinhart</surname><given-names>G. A.</given-names></name><name><surname>Chew</surname><given-names>B. P.</given-names></name></person-group><article-title>Astaxanthin stimulates cell-mediated and humoral immune responses in cats</article-title><source><italic>Veterinary Immunology and Immunopathology</italic></source><year>2011</year><volume>144</volume><issue>3-4</issue><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2011.08.019</pub-id><pub-id pub-id-type="other">2-s2.0-81555197033</pub-id><pub-id pub-id-type="pmid">21930306</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>B. P.</given-names></name><name><surname>Mathison</surname><given-names>B. D.</given-names></name><name><surname>Hayek</surname><given-names>M. G.</given-names></name><name><surname>Massimino</surname><given-names>S.</given-names></name><name><surname>Reinhart</surname><given-names>G. A.</given-names></name><name><surname>Park</surname><given-names>J. S.</given-names></name></person-group><article-title>Dietary astaxanthin enhances immune response in dogs</article-title><source><italic>Veterinary Immunology and Immunopathology</italic></source><year>2011</year><volume>140</volume><issue>3-4</issue><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2010.12.004</pub-id><pub-id pub-id-type="other">2-s2.0-79952196274</pub-id><pub-id pub-id-type="pmid">21208664</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J. S.</given-names></name><name><surname>Chyun</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>Y. K.</given-names></name><name><surname>Line</surname><given-names>L. L.</given-names></name><name><surname>Chew</surname><given-names>B. P.</given-names></name></person-group><article-title>Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans</article-title><source><italic>Nutrition &amp; Metabolism</italic></source><year>2010</year><volume>7, article 18</volume><pub-id pub-id-type="doi">10.1186/1743-7075-7-18</pub-id><pub-id pub-id-type="other">2-s2.0-77950289867</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erel</surname><given-names>O.</given-names></name></person-group><article-title>A novel automated method to measure total antioxidant response against potent free radical reactions</article-title><source><italic>Clinical Biochemistry</italic></source><year>2004</year><volume>37</volume><issue>2</issue><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2003.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-0346023040</pub-id><pub-id pub-id-type="pmid">14725941</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erel</surname><given-names>O.</given-names></name></person-group><article-title>A new automated colorimetric method for measuring total oxidant status</article-title><source><italic>Clinical Biochemistry</italic></source><year>2005</year><volume>38</volume><issue>12</issue><fpage>1103</fpage><lpage>11111</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2005.08.008</pub-id><pub-id pub-id-type="other">2-s2.0-29144527533</pub-id><pub-id pub-id-type="pmid">16214125</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alamdari</surname><given-names>D. H.</given-names></name><name><surname>Paletas</surname><given-names>K.</given-names></name><name><surname>Pegiou</surname><given-names>T.</given-names></name><name><surname>Sarigianni</surname><given-names>M.</given-names></name><name><surname>Befani</surname><given-names>C.</given-names></name><name><surname>Koliakos</surname><given-names>G.</given-names></name></person-group><article-title>A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients</article-title><source><italic>Clinical Biochemistry</italic></source><year>2007</year><volume>40</volume><issue>3-4</issue><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2006.10.017</pub-id><pub-id pub-id-type="other">2-s2.0-33846210659</pub-id><pub-id pub-id-type="pmid">17196578</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>W. T.</given-names></name><name><surname>Levy</surname><given-names>R. I.</given-names></name><name><surname>Fredrickson</surname><given-names>D. S.</given-names></name></person-group><article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title><source><italic>Clinical Chemistry</italic></source><year>1972</year><volume>18</volume><issue>6</issue><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="other">2-s2.0-0015348189</pub-id><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyonouchi</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Gross</surname><given-names>M.</given-names></name><name><surname>Tomita</surname><given-names>Y.</given-names></name></person-group><article-title>Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens</article-title><source><italic>Nutrition and Cancer</italic></source><year>1994</year><volume>21</volume><issue>1</issue><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1080/01635589409514303</pub-id><pub-id pub-id-type="other">2-s2.0-0028107320</pub-id><pub-id pub-id-type="pmid">8183722</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giri</surname><given-names>J. G.</given-names></name><name><surname>Kincade</surname><given-names>P. W.</given-names></name><name><surname>Mizel</surname><given-names>S. B.</given-names></name></person-group><article-title>Interleukin 1-mediated induction of <italic>κ</italic>-light chain synthesis and surface immunoglobulin expression of pre-B cells</article-title><source><italic>The Journal of Immunology</italic></source><year>1984</year><volume>132</volume><issue>1</issue><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="other">2-s2.0-0021356478</pub-id><pub-id pub-id-type="pmid">6418798</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naguib</surname><given-names>Y. M. A.</given-names></name></person-group><article-title>Antioxidant activities of astaxanthin and related carotenoids</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2000</year><volume>48</volume><issue>4</issue><fpage>1150</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1021/jf991106k</pub-id><pub-id pub-id-type="other">2-s2.0-0034011558</pub-id><pub-id pub-id-type="pmid">10775364</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadrilatero</surname><given-names>J.</given-names></name><name><surname>Hoffman-Goetz</surname><given-names>L.</given-names></name></person-group><article-title>N-Acetyl-L-cysteine prevents exercise-induced intestinal lymphocyte apoptosis by maintaining intracellular glutathione levels and reducing mitochondrial membrane depolarization</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2004</year><volume>319</volume><issue>3</issue><fpage>894</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.05.068</pub-id><pub-id pub-id-type="other">2-s2.0-2942567952</pub-id><pub-id pub-id-type="pmid">15184067</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>B. P.</given-names></name><name><surname>Park</surname><given-names>J. S.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Britton</surname><given-names>G.</given-names></name><name><surname>Liaanen-Jensen</surname><given-names>S.</given-names></name><name><surname>Pfander</surname><given-names>H.</given-names></name></person-group><article-title>The immune system and disease</article-title><source><italic>Carotenoids: Nutrition and Health</italic></source><year>2009</year><volume>5</volume><publisher-name>Birkhauser Press</publisher-name><fpage>363</fpage><lpage>382</lpage><series>Carotenoids Against Disease: Part C: The Immune System and Disease</series></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>T. A.</given-names></name><name><surname>Callister</surname><given-names>R.</given-names></name><name><surname>Taylor</surname><given-names>R. D.</given-names></name><name><surname>Sibbritt</surname><given-names>D. W.</given-names></name><name><surname>Macdonald-Wicks</surname><given-names>L. K.</given-names></name><name><surname>Garg</surname><given-names>M. L.</given-names></name></person-group><article-title>Antioxidant restriction and oxidative stress in short-duration exhaustive exercise</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2005</year><volume>37</volume><issue>1</issue><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000150016.46508.a1</pub-id><pub-id pub-id-type="other">2-s2.0-11344295900</pub-id><pub-id pub-id-type="pmid">15632670</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>V. H.</given-names></name><name><surname>Valente</surname><given-names>H. F.</given-names></name><name><surname>Casal</surname><given-names>S. I.</given-names></name><name><surname>Marques</surname><given-names>A. F.</given-names></name><name><surname>Moreira</surname><given-names>P. A.</given-names></name></person-group><article-title>Antioxidants do not prevent postexercise peroxidation and may delay muscle recovery</article-title><source><italic>Medicine and Science in Sports and Exercise</italic></source><year>2009</year><volume>41</volume><issue>9</issue><fpage>1752</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31819fe8e3</pub-id><pub-id pub-id-type="other">2-s2.0-69349095111</pub-id><pub-id pub-id-type="pmid">19657294</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wayner</surname><given-names>D. D. M.</given-names></name><name><surname>Burton</surname><given-names>G. W.</given-names></name><name><surname>Ingold</surname><given-names>K. U.</given-names></name><name><surname>Barclay</surname><given-names>L. R. C.</given-names></name><name><surname>Locke</surname><given-names>S. J.</given-names></name></person-group><article-title></article-title><source><italic>Biochimica et Biophysica Acta—General Subjects</italic></source><year>1987</year><volume>924</volume><issue>3</issue><fpage>408</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/0304-4165(87)90155-3</pub-id><pub-id pub-id-type="other">2-s2.0-0023662410</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>S. D.</given-names></name><name><surname>Anuradha</surname><given-names>C. V.</given-names></name></person-group><article-title>Exercise, depletion of antioxidants and antioxidant manipulation</article-title><source><italic>Cell Biochemistry and Function</italic></source><year>1998</year><volume>16</volume><issue>4</issue><fpage>269</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-0844(1998120)16:4&amp;lt;269::AID-CBF797&gt;3.0.CO;2-B</pub-id><pub-id pub-id-type="other">2-s2.0-0031785535</pub-id><pub-id pub-id-type="pmid">9857489</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>S. K.</given-names></name><name><surname>Jackson</surname><given-names>M. J.</given-names></name></person-group><article-title>Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production</article-title><source><italic>Physiological Reviews</italic></source><year>2008</year><volume>88</volume><issue>4</issue><fpage>1243</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1152/physrev.00031.2007</pub-id><pub-id pub-id-type="other">2-s2.0-55949118714</pub-id><pub-id pub-id-type="pmid">18923182</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>K. J. A.</given-names></name><name><surname>Quintanilha</surname><given-names>A. T.</given-names></name><name><surname>Brooks</surname><given-names>G. A.</given-names></name><name><surname>Packer</surname><given-names>L.</given-names></name></person-group><article-title>Free radicals and tissue damage produced by exercise</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>1982</year><volume>107</volume><issue>4</issue><fpage>1198</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1016/s0006-291x(82)80124-1</pub-id><pub-id pub-id-type="other">2-s2.0-0020383969</pub-id><pub-id pub-id-type="pmid">6291524</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>S.</given-names></name><name><surname>Kogure</surname><given-names>K.</given-names></name><name><surname>Abe</surname><given-names>K.</given-names></name><etal></etal></person-group><article-title>Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin</article-title><source><italic>Biochimica et Biophysica Acta—Biomembranes</italic></source><year>2001</year><volume>1512</volume><issue>2</issue><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/s0005-2736(01)00326-1</pub-id><pub-id pub-id-type="other">2-s2.0-0035815987</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoi</surname><given-names>W.</given-names></name><name><surname>Naito</surname><given-names>Y.</given-names></name><name><surname>Sakuma</surname><given-names>K.</given-names></name><etal></etal></person-group><article-title>Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice</article-title><source><italic>Antioxidants &amp; Redox Signaling</italic></source><year>2003</year><volume>5</volume><issue>1</issue><fpage>139</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1089/152308603321223630</pub-id><pub-id pub-id-type="other">2-s2.0-0037296150</pub-id><pub-id pub-id-type="pmid">12626126</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>P. M.</given-names></name></person-group><article-title>Role of inflammatory biomarkers in prediction of coronary heart disease</article-title><source><italic>The Lancet</italic></source><year>2001</year><volume>358</volume><issue>9286</issue><fpage>946</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(01)06112-8</pub-id><pub-id pub-id-type="other">2-s2.0-0035934563</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Salivary flow (a), salivary IgA concentration (b), and salivary IgA secretion rate (c) in soccer players at baseline and after 90 days of supplementation. Values are presented as mean ± SE. The difference in relation to baseline was significant at 0.05 (<italic>∗</italic>).</p></caption><graphic xlink:href="ECAM2015-783761.001"></graphic></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Total leukocyte count (denoted by numbers at the top of the bars); neutrophil, lymphocyte, and monocyte counts in soccer players at baseline and after 90 days of supplementation.</p></caption><graphic xlink:href="ECAM2015-783761.002"></graphic></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Subject characteristics at baseline.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"> </th><th align="center" rowspan="1" colspan="1">Astaxanthin</th><th align="center" rowspan="1" colspan="1">Placebo</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (year)</td><td align="center" rowspan="1" colspan="1">17.9 ± 0.2</td><td align="center" rowspan="1" colspan="1">17.6 ± 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">71 ± 1.7</td><td align="center" rowspan="1" colspan="1">72 ± 1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">178 ± 1.4</td><td align="center" rowspan="1" colspan="1">180 ± 1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">22.4 ± 0.3</td><td align="center" rowspan="1" colspan="1">22.2 ± 0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat (%)</td><td align="center" rowspan="1" colspan="1">9.4 ± 0.7</td><td align="center" rowspan="1" colspan="1">9.7 ± 0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2max</sub> (mL/min/kg)</td><td align="center" rowspan="1" colspan="1">55.5 ± 1.2</td><td align="center" rowspan="1" colspan="1">52.9 ± 0.7</td></tr></tbody></table><table-wrap-foot><fn><p>Values are expressed as mean ± SE.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Estimated daily energy and nutrient intake of soccer players.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"> </th><th align="center" rowspan="1" colspan="1">Asx</th><th align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Energy (kcal)</td><td align="center" rowspan="1" colspan="1">3154 ± 247</td><td align="center" rowspan="1" colspan="1">2932 ± 147</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein (g)</td><td align="center" rowspan="1" colspan="1">124 ± 8.7</td><td align="center" rowspan="1" colspan="1">125 ± 6.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrates (g)</td><td align="center" rowspan="1" colspan="1">412 ± 33</td><td align="center" rowspan="1" colspan="1">366 ± 23</td></tr><tr><td align="left" rowspan="1" colspan="1">Monosaccharides (g)</td><td align="center" rowspan="1" colspan="1">109 ± 12</td><td align="center" rowspan="1" colspan="1">123 ± 18</td></tr><tr><td align="left" rowspan="1" colspan="1">Fiber (g)</td><td align="center" rowspan="1" colspan="1">13.2 ± 1.4</td><td align="center" rowspan="1" colspan="1">12.6 ± 1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat (g)</td><td align="center" rowspan="1" colspan="1">104 ± 9</td><td align="center" rowspan="1" colspan="1">101 ± 7</td></tr><tr><td align="left" rowspan="1" colspan="1">Saturated fat (g)</td><td align="center" rowspan="1" colspan="1">33.2 ± 3.5</td><td align="center" rowspan="1" colspan="1">29.9 ± 3.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Cholesterol (mg)</td><td align="center" rowspan="1" colspan="1">328 ± 23</td><td align="center" rowspan="1" colspan="1">344 ± 38</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin A (IU)</td><td align="center" rowspan="1" colspan="1">2312 ± 442</td><td align="center" rowspan="1" colspan="1">2120 ± 389</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin C (mg)</td><td align="center" rowspan="1" colspan="1">149 ± 25</td><td align="center" rowspan="1" colspan="1">135 ± 30</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin E (mg)</td><td align="center" rowspan="1" colspan="1">5.4 ± 0.7</td><td align="center" rowspan="1" colspan="1">6.1 ± 1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Copper (mg)</td><td align="center" rowspan="1" colspan="1">2.3 ± 0.4</td><td align="center" rowspan="1" colspan="1">1.92 ± 0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Iron (mg)</td><td align="center" rowspan="1" colspan="1">14.4 ± 0.9</td><td align="center" rowspan="1" colspan="1">15.1 ± 1.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Manganese (mg)</td><td align="center" rowspan="1" colspan="1">4.9 ± 0.3</td><td align="center" rowspan="1" colspan="1">4.0 ± 0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Selenium (<italic>μ</italic>g)</td><td align="center" rowspan="1" colspan="1">187 ± 15</td><td align="center" rowspan="1" colspan="1">164 ± 8</td></tr><tr><td align="left" rowspan="1" colspan="1">Zinc (mg)</td><td align="center" rowspan="1" colspan="1">13.0 ± 1.4</td><td align="center" rowspan="1" colspan="1">13.5 ± 1.8</td></tr></tbody></table><table-wrap-foot><fn><p>Values are expressed as mean ± SE.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Oxidative stress status of the soccer players at baseline and after 90 days of supplementation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"> </th><th align="center" colspan="2" rowspan="1">Astaxanthin</th><th align="center" colspan="2" rowspan="1">Placebo</th><th align="center" colspan="3" rowspan="1">ANOVA</th></tr><tr><th align="left" rowspan="1" colspan="1"> </th><th align="center" rowspan="1" colspan="1">Before supplementation</th><th align="center" rowspan="1" colspan="1">After supplementation</th><th align="center" rowspan="1" colspan="1">Before supplementation</th><th align="center" rowspan="1" colspan="1">After supplementation</th><th align="center" rowspan="1" colspan="1"> T </th><th align="center" rowspan="1" colspan="1">S</th><th align="center" rowspan="1" colspan="1">T × S</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TAS (mmolTrolox equiv./L)</td><td align="center" rowspan="1" colspan="1">0.551 ± 0.036</td><td align="center" rowspan="1" colspan="1">0.538 ± 0.029</td><td align="center" rowspan="1" colspan="1">0.532 ± 0.039</td><td align="center" rowspan="1" colspan="1">0.585 ± 0.031</td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">TOS (mmol/L)</td><td align="center" rowspan="1" colspan="1">15.4 ± 1.5</td><td align="center" rowspan="1" colspan="1">5.0 ± 0.5<sup><italic>∗∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">16.8 ± 1.6</td><td align="center" rowspan="1" colspan="1">5.1 ± 0.5<sup><italic>∗∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">PAB (HK U)</td><td align="center" rowspan="1" colspan="1">479.1 ± 45.4</td><td align="center" rowspan="1" colspan="1">291.5 ± 33.3<sup><italic>∗∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">338.9 ± 48.8</td><td align="center" rowspan="1" colspan="1">258.9 ± 35.8</td><td align="center" rowspan="1" colspan="1">&lt;0.001 </td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">&lt;0.05</td></tr></tbody></table><table-wrap-foot><fn><p>Values are expressed as mean ± SE. ANOVA: T-training, S-supplementation, and T × S-training and supplementation interaction effect. </p></fn><fn><p>The difference in relation to baseline was significant at <italic>p</italic> &lt; 0.001 (<sup><italic>∗∗∗</italic></sup>).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Biochemical profile of the soccer players at baseline and after 90 days of supplementation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"> </th><th align="center" colspan="2" rowspan="1">Astaxanthin</th><th align="center" colspan="2" rowspan="1">Placebo</th><th align="center" colspan="3" rowspan="1">ANOVA</th></tr><tr><th align="left" rowspan="1" colspan="1"> </th><th align="center" rowspan="1" colspan="1">Before supplementation</th><th align="center" rowspan="1" colspan="1">After supplementation</th><th align="center" rowspan="1" colspan="1">Before supplementation</th><th align="center" rowspan="1" colspan="1">After supplementation</th><th align="center" rowspan="1" colspan="1">T </th><th align="center" rowspan="1" colspan="1">S</th><th align="center" rowspan="1" colspan="1">T × S</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AST (U/L)<sup>†</sup>
</td><td align="center" rowspan="1" colspan="1">37.5 (29.2–48.1)</td><td align="center" rowspan="1" colspan="1">23.8 (20.1–28.1)<sup><italic>∗∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">41.0 (35.7–47.0)</td><td align="center" rowspan="1" colspan="1">28.7 (24.5–33.6)<sup><italic>∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1"> 0.001 </td><td align="center" rowspan="1" colspan="1">&lt;0.05</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT (U/L)<sup>†</sup>
</td><td align="center" rowspan="1" colspan="1">21.1 (16.8–25.6)</td><td align="center" rowspan="1" colspan="1">18.9 (15.6–21.6)</td><td align="center" rowspan="1" colspan="1">20.7 (18.6–22.5)</td><td align="center" rowspan="1" colspan="1">19.2 (16.1–22.6)</td><td align="center" rowspan="1" colspan="1"> ns </td><td align="center" rowspan="1" colspan="1">ns </td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">CK (U/L)<sup>†</sup>
</td><td align="center" rowspan="1" colspan="1">448 (330–608)</td><td align="center" rowspan="1" colspan="1">248 (172–360)<sup><italic>∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">525 (283–974)</td><td align="center" rowspan="1" colspan="1">367 (244–552)</td><td align="center" rowspan="1" colspan="1"> &lt;0.01 </td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">LDH (U/L)<sup>‡</sup>
</td><td align="center" rowspan="1" colspan="1">418.3 ± 13.8</td><td align="center" rowspan="1" colspan="1">303.5 ± 10.3<sup><italic>∗∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">441.2 ± 17.5</td><td align="center" rowspan="1" colspan="1">359.4 ± 15.8<sup><italic>∗</italic></sup>
</td><td align="center" rowspan="1" colspan="1">&lt;0.001 </td><td align="center" rowspan="1" colspan="1">&lt;0.05 </td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">UA (<italic>μ</italic>mol/L)<sup>†</sup>
</td><td align="center" rowspan="1" colspan="1">330.3 ± 19.1</td><td align="center" rowspan="1" colspan="1">300.4 ± 14.0</td><td align="center" rowspan="1" colspan="1">346.5 ± 20.9</td><td align="center" rowspan="1" colspan="1">315.9 ± 15.5</td><td align="center" rowspan="1" colspan="1">&lt;0.05 </td><td align="center" rowspan="1" colspan="1">ns </td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">Cre (<italic>μ</italic>mol/L)<sup>†</sup>
</td><td align="center" rowspan="1" colspan="1">129.6 ± 2.1</td><td align="center" rowspan="1" colspan="1">126.5 ± 2.2</td><td align="center" rowspan="1" colspan="1">133.1 ± 2.3</td><td align="center" rowspan="1" colspan="1">130.5 ± 2.4</td><td align="center" rowspan="1" colspan="1">&lt;0.05 </td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">hs-CRP (mg/L)<sup>†</sup>
</td><td align="center" rowspan="1" colspan="1">1.35 (1.00–1.82)</td><td align="center" rowspan="1" colspan="1">1.19 (0.89–1.59)</td><td align="center" rowspan="1" colspan="1">1.26 (0.89–1.78)</td><td align="center" rowspan="1" colspan="1">1.98 (1.24–3.17)</td><td align="center" rowspan="1" colspan="1"> ns </td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">CHOL (mmol/L)<sup>‡</sup>
</td><td align="center" rowspan="1" colspan="1">4.28 ± 0.20</td><td align="center" rowspan="1" colspan="1">4.39 ± 0.24</td><td align="center" rowspan="1" colspan="1">4.54 ± 0.28</td><td align="center" rowspan="1" colspan="1">4.50 ± 0.27</td><td align="center" rowspan="1" colspan="1"> ns </td><td align="center" rowspan="1" colspan="1">ns </td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-C (mmol/L)<sup>‡</sup>
</td><td align="center" rowspan="1" colspan="1">1.27 ± 0.19</td><td align="center" rowspan="1" colspan="1">1.30 ± 0.05</td><td align="center" rowspan="1" colspan="1">1.29 ± 0.07</td><td align="center" rowspan="1" colspan="1">1.31 ± 0.06</td><td align="center" rowspan="1" colspan="1"> ns </td><td align="center" rowspan="1" colspan="1">ns </td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-C (mmol/L)<sup>‡</sup>
</td><td align="center" rowspan="1" colspan="1">2.63 ± 0.19</td><td align="center" rowspan="1" colspan="1">2.73 ± 0.20</td><td align="center" rowspan="1" colspan="1">2.97 ± 0.24</td><td align="center" rowspan="1" colspan="1">2.91 ± 0.25</td><td align="center" rowspan="1" colspan="1"> ns </td><td align="center" rowspan="1" colspan="1">ns </td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mmol/L)<sup>‡</sup>
</td><td align="center" rowspan="1" colspan="1">0.84 ± 0.12</td><td align="center" rowspan="1" colspan="1">0.80 ± 0.08</td><td align="center" rowspan="1" colspan="1">0.95 ± 0.14</td><td align="center" rowspan="1" colspan="1">0.70 ± 0.09</td><td align="center" rowspan="1" colspan="1"> ns </td><td align="center" rowspan="1" colspan="1">ns </td><td align="center" rowspan="1" colspan="1">ns</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>‡</sup>Mean ± SE.; <sup>†</sup>Geometric mean values (95th confidence interval). ANOVA: T-training, S-supplementation, and T × S-training and supplementation interaction effect. The difference in relation to baseline was significant at <italic>p</italic> &lt; 0.05 (<sup><italic>∗</italic></sup>), <italic>p</italic> &lt; 0.01 (<sup><italic>∗∗</italic></sup>), and <italic>p</italic> &lt; 0.001 (<sup><italic>∗∗∗</italic></sup>).</p></fn></table-wrap-foot></table-wrap></floats-group></article>